SEMAGLUTIDE (Ozempic) Swiss Elite Laboratories 5 mg is formulated as a 5 mg semaglutide research product for laboratory-focused investigation. Semaglutide is a peptide associated with GLP-1 receptor activity and has been extensively examined in metabolic research. Researchers may consult relevant scientific literature and manufacturer documentation when evaluating its suitability for a particular experimental protocol. Product handling should follow appropriate laboratory procedures, including applicable storage and preparation requirements. This information is provided for research description purposes and should not be considered medical or treatment advice.